Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 450

1.

Immunoregulation of Theiler's virus-induced demyelinating disease by glatiramer acetate without suppression of antiviral immune responses.

Omura S, Sato F, Martinez NE, Range T, Ekshyyan L, Minagar A, Alexander JS, Tsunoda I.

Arch Virol. 2018 May;163(5):1279-1284. doi: 10.1007/s00705-018-3729-6. Epub 2018 Jan 23.

PMID:
29362931
2.

Neuronal CCL2 expression drives inflammatory monocyte infiltration into the brain during acute virus infection.

Howe CL, LaFrance-Corey RG, Goddery EN, Johnson RK, Mirchia K.

J Neuroinflammation. 2017 Dec 4;14(1):238. doi: 10.1186/s12974-017-1015-2.

3.

Pegylated interferon beta in the treatment of the Theiler's murine encephalomyelitis virus mouse model of multiple sclerosis.

Gilli F, Royce DB, DiSano KD, Pachner AR.

J Neuroimmunol. 2017 Dec 15;313:34-40. doi: 10.1016/j.jneuroim.2017.10.004. Epub 2017 Oct 9.

PMID:
29153606
4.

Treatment of Theiler's virus-induced demyelinating disease with teriflunomide.

Gilli F, Li L, Royce DB, DiSano KD, Pachner AR.

J Neurovirol. 2017 Dec;23(6):825-838. doi: 10.1007/s13365-017-0570-8. Epub 2017 Sep 14.

PMID:
28913765
5.

Three immune-mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis.

Tsunoda I, Sato F, Omura S, Fujita M, Sakiyama N, Park AM.

Clin Exp Neuroimmunol. 2016 Nov;7(4):330-345. doi: 10.1111/cen3.12341. Epub 2016 Oct 25.

6.

Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy.

DePaula-Silva AB, Hanak TJ, Libbey JE, Fujinami RS.

J Neuroimmunol. 2017 Jul 15;308:30-42. doi: 10.1016/j.jneuroim.2017.02.012. Epub 2017 Feb 12. Review.

7.

Roles of regulatory T cells and IL-10 in virus-induced demyelination.

Perlman S, Zhao J.

J Neuroimmunol. 2017 Jul 15;308:6-11. doi: 10.1016/j.jneuroim.2017.01.001. Epub 2017 Jan 4. Review.

8.

Viral mouse models of multiple sclerosis and epilepsy: Marked differences in neuropathogenesis following infection with two naturally occurring variants of Theiler's virus BeAn strain.

Bröer S, Hage E, Käufer C, Gerhauser I, Anjum M, Li L, Baumgärtner W, Schulz TF, Löscher W.

Neurobiol Dis. 2017 Mar;99:121-132. doi: 10.1016/j.nbd.2016.12.020. Epub 2016 Dec 22.

PMID:
28017800
9.

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis.

Gilli F, Royce DB, Pachner AR.

J Vis Exp. 2016 Nov 14;(117). doi: 10.3791/54616.

PMID:
27911409
10.

Human class I major histocompatibility complex alleles determine central nervous system injury versus repair.

Wootla B, Denic A, Watzlawik JO, Warrington AE, Zoecklein LJ, Papke-Norton LM, David C, Rodriguez M.

J Neuroinflammation. 2016 Nov 17;13(1):293.

11.

The role of α4 integrin in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease: an infectious animal model for multiple sclerosis (MS).

Hirano Y, Kobayashi K, Tomiki H, Inaba Y, Ichikawa M, Kim BS, Koh CS.

Int Immunol. 2016 Dec;28(12):575-584. doi: 10.1093/intimm/dxw045. Epub 2016 Nov 1.

PMID:
27803063
12.

Viral Infection of the Central Nervous System Exacerbates Interleukin-10 Receptor Deficiency-Mediated Colitis in SJL Mice.

Uhde AK, Herder V, Akram Khan M, Ciurkiewicz M, Schaudien D, Teich R, Floess S, Baumgärtner W, Huehn J, Beineke A.

PLoS One. 2016 Sep 9;11(9):e0161883. doi: 10.1371/journal.pone.0161883. eCollection 2016.

13.

Transgenic expression of non-structural genes of Theiler's virus suppresses initial viral replication and pathogenesis of demyelination.

Kang HS, Myoung J, So EY, Bahk YY, Kim BS.

J Neuroinflammation. 2016 Jun 1;13(1):133. doi: 10.1186/s12974-016-0597-4.

14.

A monoclonal natural human IgM protects axons in the absence of remyelination.

Wootla B, Denic A, Warrington AE, Rodriguez M.

J Neuroinflammation. 2016 Apr 28;13(1):94. doi: 10.1186/s12974-016-0561-3.

15.

During Infection, Theiler's Virions Are Cleaved by Caspases and Disassembled into Pentamers.

Arslan SY, Son KN, Lipton HL.

J Virol. 2016 Jan 20;90(7):3573-83. doi: 10.1128/JVI.03035-15.

16.

Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler's virus-induced demyelinating disease.

Li L, Ulrich R, Baumgärtner W, Gerhauser I.

J Neuroinflammation. 2015 Dec 24;12:242. doi: 10.1186/s12974-015-0462-x.

17.

The effect of B-cell depletion in the Theiler's model of multiple sclerosis.

Gilli F, Li L, Campbell SJ, Anthony DC, Pachner AR.

J Neurol Sci. 2015 Dec 15;359(1-2):40-7. doi: 10.1016/j.jns.2015.10.012. Epub 2015 Oct 8.

PMID:
26671084
18.

[Molecular genetic characteristics of the virus isolated from patients with human acute encephalomyelitis and multiple sclerosis].

Barinsky IF, Grebennikova TV, Alkhovsky SV, Kochergin-Nikitsky KS, Sergeyev OV, Gribencha SV, Raev SA.

Vopr Virusol. 2015;60(4):14-8. Russian.

PMID:
26665429
19.

Depletion of Olig2 in oligodendrocyte progenitor cells infected by Theiler's murine encephalomyelitis virus.

Benner B, Martorell AJ, Mahadevan P, Najm FJ, Tesar PJ, Freundt EC.

J Neurovirol. 2016 Jun;22(3):336-48. doi: 10.1007/s13365-015-0402-7. Epub 2015 Dec 2.

PMID:
26631080
20.

Social disruption alters pain and cognition in an animal model of multiple sclerosis.

Linsenbardt HR, Cook JL, Young EE, Vichaya EG, Young CR, Reusser NM, Storts R, Welsh CJ, Meagher MW.

J Neuroimmunol. 2015 Nov 15;288:56-68. doi: 10.1016/j.jneuroim.2015.09.005. Epub 2015 Sep 12.

Supplemental Content

Loading ...
Support Center